PARTNERSHIP

VisMederi has performed business management and review of Open Label Phase I / II / III studies to assess the immunogenicity of Influenza Vaccines in healthy adults and the elderly with National and International Public and Private Institutions and Companies.

VisMederi contract services are offered both for early and later phases of development.